These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 35699913)

  • 1. Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models.
    Berton M; Bettonte S; Stader F; Battegay M; Marzolini C
    Clin Pharmacokinet; 2022 Sep; 61(9):1251-1270. PubMed ID: 35699913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repository Describing an Aging Population to Inform Physiologically Based Pharmacokinetic Models Considering Anatomical, Physiological, and Biological Age-Dependent Changes.
    Stader F; Siccardi M; Battegay M; Kinvig H; Penny MA; Marzolini C
    Clin Pharmacokinet; 2019 Apr; 58(4):483-501. PubMed ID: 30128967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals.
    Berton M; Bettonte S; Stader F; Battegay M; Marzolini C
    Clin Pharmacokinet; 2023 Feb; 62(2):277-295. PubMed ID: 36571702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
    Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
    Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
    Ghobadi C; Johnson TN; Aarabi M; Almond LM; Allabi AC; Rowland-Yeo K; Jamei M; Rostami-Hodjegan A
    Clin Pharmacokinet; 2011 Dec; 50(12):809-22. PubMed ID: 22087867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.
    Abduljalil K; Furness P; Johnson TN; Rostami-Hodjegan A; Soltani H
    Clin Pharmacokinet; 2012 Jun; 51(6):365-96. PubMed ID: 22515555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy.
    Dallmann A; Ince I; Meyer M; Willmann S; Eissing T; Hempel G
    Clin Pharmacokinet; 2017 Nov; 56(11):1303-1330. PubMed ID: 28401479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-Related Changes in Pediatric Physiology: Quantitative Analysis of Organ Weights and Blood Flows : Age-Related Changes in Pediatric Physiology.
    Chang HP; Kim SJ; Wu D; Shah K; Shah DK
    AAPS J; 2021 Mar; 23(3):50. PubMed ID: 33791883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows.
    Rasool MF; Khalil F; Läer S
    Clin Pharmacokinet; 2015 Sep; 54(9):943-62. PubMed ID: 25773479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations.
    Krauss M; Tappe K; Schuppert A; Kuepfer L; Goerlitz L
    PLoS One; 2015; 10(10):e0139423. PubMed ID: 26431198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling.
    Gerhart JG; Carreño FO; Edginton AN; Sinha J; Perrin EM; Kumar KR; Rikhi A; Hornik CP; Harris V; Ganguly S; Cohen-Wolkowiez M; Gonzalez D;
    Clin Pharmacokinet; 2022 Feb; 61(2):307-320. PubMed ID: 34617262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological parameter values for physiologically based pharmacokinetic models in food-producing animals. Part I: Cattle and swine.
    Lin Z; Li M; Wang YS; Tell LA; Baynes RE; Davis JL; Vickroy TW; Riviere JE
    J Vet Pharmacol Ther; 2020 Sep; 43(5):385-420. PubMed ID: 32270548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feeding the critically ill obese patient: a systematic review protocol.
    Secombe P; Harley S; Chapman M; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):95-109. PubMed ID: 26571286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal Physiologically Based Pharmacokinetic Models: Systems Information on the Growth and Composition of Fetal Organs.
    Abduljalil K; Jamei M; Johnson TN
    Clin Pharmacokinet; 2019 Feb; 58(2):235-262. PubMed ID: 29987449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Obesity on Hepatic Drug Clearance: What are the Influential Variables?
    Zhang T; Calvier EAM; Krekels EHJ; Knibbe CAJ
    AAPS J; 2024 May; 26(3):59. PubMed ID: 38724865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly.
    Thompson CM; Johns DO; Sonawane B; Barton HA; Hattis D; Tardif R; Krishnan K
    J Toxicol Environ Health B Crit Rev; 2009 Jan; 12(1):1-24. PubMed ID: 19117207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.
    Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G
    Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Obesity on the Drug-Drug Interaction Between Dolutegravir and Rifampicin or Any Other Strong Inducers.
    Berton M; Bettonte S; Stader F; Battegay M; Marzolini C
    Open Forum Infect Dis; 2023 Jul; 10(7):ofad361. PubMed ID: 37496606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of physiologically based pharmacokinetic modeling to predict the pharmacokinetics of telavancin in obesity with renal impairment.
    Wu W; Ke M; Ye L; Lin C
    Eur J Clin Pharmacol; 2021 Jul; 77(7):989-998. PubMed ID: 33447912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the Elderly.
    Stader F; Kinvig H; Penny MA; Battegay M; Siccardi M; Marzolini C
    Clin Pharmacokinet; 2020 Mar; 59(3):383-401. PubMed ID: 31583609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.